Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
erxian decoction
- Development stage
- Unknown
- Lead developer
- Guilin People's Hospital
- Administration
- Oral
01
Overview
Erxian Decoction (EXD) is a classic Traditional Chinese Medicine (TCM) formula composed of six herbs: *Herba Epimedii* (Yinyanghuo), *Rhizoma Curculiginis* (Xianmao), *Radix Angelicae Sinensis* (Danggui), *Rhizoma Anemarrhenae* (Zhimu), *Cortex Phellodendri* (Huangbai), and *Radix Morindae Officinalis* (Bajitian). Originally formulated to treat menopausal syndrome by tonifying kidney yang and essence while purging kidney fire, it is now widely investigated for its regulatory effects on the hypothalamic-pituitary-gonadal (HPG) axis. In clinical research, EXD is being evaluated for its efficacy in treating late-onset hypogonadism (LOH) and associated lower urinary tract symptoms (LUTS) in males. Its mechanism of action involves modulating hormone levels, including testosterone and estradiol, and exerting anti-inflammatory and antioxidant effects to improve endocrine and urological function.
- Other names
- Erxian TangTwo-Immortal DecoctionEXD
02
Targets
ESR2 (ERβ)AR (Adrenergic receptors)ESR1 (ERα)
Beyond the preview
Go deeper on erxian decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on erxian decoction.